P2‐250: NOVEL STATISTICALLY‐DERIVED COMPOSITE MEASURES FOR ASSESSING THE EFFICACY OF DISEASE‐MODIFYING THERAPIES IN PRODROMAL AD TRIALS: AN AIPL STUDY. (1st July 2014)